Case Report: Postoperative central nervous system infections caused by carbapenem-resistant Acinetobacter baumannii

Sulbactam–durlobactam in combination with a carbapenem is recommended as the preferred treatment for invasive carbapenem-resistant Acinetobacter baumannii (CRAB) infections in the 2026 Infectious Diseases Society of America guidance. However, clinical experience with sulbactam–durlobactam for treating CRAB-induced central nervous system (CNS) infections remains extremely limited, and intraventricular/intrathecal polymyxins are still recommended as established therapy for CRAB ventriculitis/meningitis. We report two cases of CRAB-induced CNS meningitis/ventriculitis that occurred following cranial neurosurgery. Both patients presented with recurrent fever and altered mental status after brain surgery and showed an inadequate response to conventional antimicrobial regimens, including intravenous polymyxin B with intrathecal or intraventricular administration. After conversion to combination therapy of sulbactam–durlobactam and meropenem, along with neurosurgical intervention, both patients achieved fever control and sustained microbiological and laboratory improvement. These cases provide additional clinical evidence suggesting that, in patients with surgically disrupted blood–brain barriers, intravenous administration of sulbactam–durlobactam in combination with meropenem may represent an effective therapeutic option for CNS infections caused by CRAB. However, the applicability of this regimen may be limited to patients with blood–brain barrier impairment. Its use in this population still requires further pharmacokinetic validation.

Authors

Institutions

Publication Details

Journal
Frontiers in Medicine
Published
2026-11-13
DOI
https://doi.org/10.3389/fmed.2026.1956307
Primary Topic
Antibiotic Resistance in Bacteria
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Case Report: Postoperative central nervous system infections caused by carbapenem-resistant Acinetobacter baumannii

Yunan Chang, 毛日成, Lingyun Shao, Huazhen Zhao et al.
5 links
Frontiers in Medicine
Antibiotic Resistance in Bacteria
article

Case Report: Postoperative central nervous system infections caused by carbapenem-resistant Acinetobacter baumannii

Yunan Chang, 毛日成, Lingyun Shao, Huazhen Zhao, Huaiyin Zhao, Lei Shen
article en

Abstract

Sulbactam–durlobactam in combination with a carbapenem is recommended as the preferred treatment for invasive carbapenem-resistant Acinetobacter baumannii (CRAB) infections in the 2026 Infectious Diseases Society of America guidance. However, clinical experience with sulbactam–durlobactam for treating CRAB-induced central nervous system (CNS) infections remains extremely limited, and intraventricular/intrathecal polymyxins are still recommended as established therapy for CRAB ventriculitis/meningitis. We report two cases of CRAB-induced CNS meningitis/ventriculitis that occurred following cranial neurosurgery. Both patients presented with recurrent fever and altered mental status after brain surgery and showed an inadequate response to conventional antimicrobial regimens, including intravenous polymyxin B with intrathecal or intraventricular administration. After conversion to combination therapy of sulbactam–durlobactam and meropenem, along with neurosurgical intervention, both patients achieved fever control and sustained microbiological and laboratory improvement. These cases provide additional clinical evidence suggesting that, in patients with surgically disrupted blood–brain barriers, intravenous administration of sulbactam–durlobactam in combination with meropenem may represent an effective therapeutic option for CNS infections caused by CRAB. However, the applicability of this regimen may be limited to patients with blood–brain barrier impairment. Its use in this population still requires further pharmacokinetic validation.

Frontiers in MedicineVol. 13
Fudan University (CN), Children's Hospital of Chongqing Medical University (CN), Huashan Hospital (CN), Chongqing Medical University (CN)
Good health and well-being
Antibiotic Resistance in Bacteria
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon